Pharma AI Governance: Novartis CEO Joins Anthropic Board
Examine the impact of Novartis CEO Vas Narasimhan joining Anthropic's board. This report analyzes pharma AI governance, healthcare regulations, and drug R&D.
Back to Articles
Articles tagged with “ai-regulation”
Algorithmic Redlining: How AI Bias Works & How to Stop It
Understand algorithmic redlining, a form of AI bias creating housing and lending discrimination. Explore its causes, legal frameworks including the EU AI Act and state enforcement, and effective technical solutions. Updated with 2025-2026 enforcement actions, CFPB changes, and Colorado AI Act developments.